Adverse Effects of Medication
Introduction to Adverse Effects
- The American Thoracic Society, American Academy of Ophthalmology, and American College of Cardiology recommend monitoring for gastrointestinal, neurological, and dermatological effects, including nausea, vomiting, diarrhea, abdominal discomfort, headache, dizziness, blurred vision, skin rashes, pruritus, and increased skin pigmentation, as these are common adverse effects 1
- The American Academy of Ophthalmology notes that early detection of adverse effects is critical, and symptoms include difficulty reading, decreased vision, and glare 2
Ocular Toxicity
- The American Academy of Ophthalmology states that retinopathy is a major dose-limiting toxicity with long-term use, with risk increasing with higher daily doses (>5.0 mg/kg of real body weight), and recommends regular ophthalmologic screening every 6-12 months for long-term users to detect retinopathy early, as damage may be irreversible 1, 2
- The risk of retinal toxicity increases with higher doses and longer duration, affecting 0.5% after 6 years, increasing to 7.5% of long-term users, and >20% after 20 years, according to the American Academy of Ophthalmology 3
- A complete ophthalmologic examination is recommended before starting treatment, and ongoing ophthalmologic examination every 6-12 months for long-term users, as suggested by the American Academy of Ophthalmology 2
Cardiovascular Effects
- The American College of Cardiology and American Heart Association note that QT prolongation, risk of arrhythmias, and cardiomyopathy can occur with long-term use, and recommend monitoring for cardiomyopathy and periodic ECG in patients on long-term therapy, especially with chloroquine 1
- The risk of QT prolongation and torsade de pointes is increased when combined with certain antineoplastics, antiemetics, and antidepressants, according to the European Medicines Agency 4
Hematological Effects
- The American Society of Hematology states that hemolytic anemia can occur in patients with G6PD deficiency, and myelosuppression is rare, but can occur 1
- Regular monitoring of complete blood count is recommended during treatment with hydroxychloroquine, as suggested by the American College of Chest Physicians and the American Heart Association 1, 5
Musculoskeletal Effects
- The American Academy of Neurology states that peripheral neuropathy and skeletal muscle myopathy can occur with prolonged therapy 1
- The risk of peripheral neuropathy is increased when combined with platinum salts, anthracyclines, and taxanes, according to the American Academy of Neurology 4
Baseline Assessment and Ongoing Monitoring
- The American College of Cardiology recommends ECG if cardiac risk factors are present, and periodic ECG in patients on long-term therapy, especially with chloroquine 1
- The American Academy of Ophthalmology recommends a complete ophthalmologic examination before starting treatment, and ongoing ophthalmologic examination every 6-12 months for long-term users 2
- Regular monitoring of liver function, complete blood count, and renal function is recommended during treatment with hydroxychloroquine, as suggested by the American College of Chest Physicians and the American Heart Association 1, 5
Indications and Usage
- Hydroxychloroquine is a conventional synthetic disease-modifying antirheumatic drug (csDMARD) used to treat autoimmune and inflammatory conditions, with mechanisms including immunomodulatory effects, anti-inflammatory properties, and antiviral properties, as supported by the American College of Rheumatology 5, 6, 1
- The American College of Rheumatology recommends hydroxychloroquine for patients with systemic lupus erythematosus (SLE), including those with lupus nephritis, unless contraindicated, due to its benefits in reducing disease flares, organ damage, and mortality 3
- Weight-based dosing: ≤5.0 mg/kg based on actual body weight provides low risk of toxicity (less than 2% with up to 10 years of use), and renal adjustment is recommended, as suggested by the National Kidney Foundation 7, 3
Patient Education and Safety
- Patient education on reporting visual changes, new or worsening neuropsychiatric symptoms, signs of hypoglycemia, and avoiding prolonged sun exposure or using sunscreen is crucial for safe long-term use of hydroxychloroquine, as suggested by the American College of Chest Physicians 1
- Common side effects include gastrointestinal symptoms, neurological symptoms, and dermatological symptoms, and potential rare but serious side effects include retinopathy, QT interval prolongation, cardiomyopathy, hemolytic anemia, myelosuppression, elevated liver enzymes, severe hypoglycemia, and skeletal muscle myopathy or neuropathy, as reported by the European Respiratory Society, the American Gastroenterological Association, and the CDC recommendations 8, 9, 10
- Hydroxychloroquine should not be avoided solely due to concerns about retinopathy, and the goal of retinal screening is to safely maintain this valuable medication for as long as possible, according to the American Academy of Ophthalmology and the American College of Rheumatology 7
Special Considerations
- Hydroxychloroquine is generally considered safe during pregnancy, with decreased lupus activity and satisfactory safety profile for mother and fetus, as stated by the American College of Obstetricians and Gynecologists 3
- Hydroxychloroquine can be continued during COVID-19 exposure or infection, unlike many other immunosuppressive medications, but monitoring for QT prolongation is required, especially when combined with other QT-prolonging medications, as reported by the European Respiratory Society and the American Gastroenterological Association 11, 12, 8, 9
- Hydroxychloroquine has been used in pediatric patients with rheumatic diseases for years, generally considered safe, as reported by the American Academy of Pediatrics 1, 13